Clenbuterol to Target DUX4 in FSHD

Clinical trial NCT06721299 · RECRUITING

Trial details

NCT number: NCT06721299
Sponsor: Jeffrey Statland
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Muscular Dystrophy, Facioscapulohumeral

Start date: 2025-06-25
Primary completion: 2028-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.